The purpose of this study is to identify specific barriers to preventing a late stage cancer diagnosis within communities identified in North Carolina as having a higher rate of advanced cancer diagnoses.
The purpose of this study is to create a registry that will collect clinical data from participants attending UNC Hospitals who may present with metastatic cancer and are evaluated to receive radiation therapy. We hope to create a registry that future studies can pull from to study the impacts of radiation therapy on patient cancer outcomes.
The purpose of this research study is to see how effective the use of copper Cu 64 PSMA I&T Injection is in imaging prostate cancer tumors for staging of men with newly diagnosed intermediate or high risk prostate cancer who are planned to have radical prostatectomy with pelvic lymph node dissection.
Collecting data on chronic GVHD instances
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.
This project is a randomized clinical trial (study that randomly assigns participants to one arm to fairly understand outcomes) that aims to assess if information from gene expression classifier (GEC) testing is helpful for both patients and their doctors in the management of care for newly diagnosed prostate cancer patients.
We are determining whether upper extremity function improves after surgery for patients presenting with upper extremity lymphedema.
Aim 1: To co-develop the "Patient-Centered Pharmacy Pathway for Oral Chemotherapy" (P3OC) components through stakeholder engagement by conducting a modified Delphi panel with pharmacists, physicians, and other oncology healthcare providers (36,37) to determine key symptoms to assess during oral chemotherapy. Aim 2: To conduct usability testing(38,39) of the P3OC EHR Smart Form, verbal PROM, and report/dashboard with pharmacists.
This study will evaluate the safety and tolerability of EG 70, a gene therapy, which is given inside the bladder, and its effectiveness on eliminating bladder tumors in patients with NMIBC who have failed BCG therapy and have been recommended to have their bladder removed. Giving the study drug inside the bladder is to expose cells in the lining of the bladder, including your cancerous cells, to genes that may cause an immune response inside the bladder and kill the tumor cells.
To discover how different forms of radiation affect the sleep, mood, and social function of adults with brain cancer. Doctors have suspected that these patients may be getting worse sleep, but no one has studied it. Since sleep is important in recovery and overall body function, understanding how radiation changes it will lead to a greater clinical understanding of the treatment.